ACHC Company Profile and Key Details

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) closed at $20.84 USD, gaining $3.67 (21.37%) from the previous close of $17.17. The stock is currently mid-range between its 52-week high and low $11.43 and $42.85. With a market capitalization of about $1.88 billion, Acadia Healthcare Company, Inc. is classified as a small-cap and shows market-like volatility (beta ~0.88). Key stats such as the average daily volume over the past year has been around 3.52 million shares, trading with heavier-than-usual volume. Headquartered in Franklin, TN, Acadia Healthcare Company, Inc. operates in the Healthcare sector and the Medical - Care Facilities industry. Led by CEO Debra K. Osteen, the company employs approximately 25,500 people and listed since March 04, 1994. Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico.

ACHC has shown mixed momentum, gaining 7.63% over the past week and -41.07% over the past quarter, though year-to-date performance is up 0.35%. Short-term trend indicators are mixed aligned (SMA20 36.7%, SMA50 43.74%, SMA200 4.74%). The stock’s 14-day RSI is 80.5 (overbought), while the ATR of 1.19 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -51.37% below its high and over 82.33% above its low. Average 10-day trading volume of 3.84 million shares is in line with the 3-month average of 3.61 million, indicating normal recent market interest.

Acadia Healthcare Company, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $46.67. This means the shares are trading below this model’s fair value.

Acadia Healthcare Company, Inc. has 90.44 million shares outstanding. The public float is 82.35 million shares, elevated short interest at 33.98% of float. This equals 26.36 million shares. The short ratio is 7.37 days. Institutional investors hold 129.5% of the float. Insiders own 1.84%. WAUD CAPITAL PARTNERS II, L.L.C. holds 3.87 million shares, WAUD CAPITAL PARTNERS III, L.L.C. has 1.84 million shares and OSTEEN DEBRA K has 675.83 thousand shares.

Acadia Healthcare Company, Inc. generated EPS of $1.18 over the past year. Five-year average earnings growth is 17.49%. Wall Street analysts project EPS growth of -17.72% annually over the next five years. The latest quarter delivered EPS of $0.72. The next quarter is forecast at $0.01. Next year's EPS is expected at $9.93. Analyst sentiment is bullish. Analyst rating data shows there are 11 Strong Buy ratings, 10 Buy ratings, 12 Hold ratings, 0 Sell rating and 1 Strong Sell ratings. Price targets range from $65.00 to $15.00. The high target offers 211.9% upside. The low target suggests -28.02% downside. The mean target is $28.21. This offers 35.36% upside. Acadia Healthcare Company, Inc. earnings surprise history is a mixed track record. The quarter that ended November 05, 2025, missed forecasts by 5.88%. The prior quarter beat by 16.9%. Over the last six quarters, Apple has recorded several small beats. These include 4.6% in July 31, 2024.

Acadia Healthcare Company, Inc. trades at a P/E ratio of -1.78, slightly below the S&P 500 average, with a price-to-sales ratio of 0.59 and a price-to-book ratio of 1.01 suggesting the stock is closer to book value. The P/FCF stands at -5.66, also below market averages.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) shares are flat 0.35% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Acadia Healthcare Company, Inc. trading at a premium to the broader market with a P/E of -1.78. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $58.09, suggesting 178.74% upside. Our AI forecast model points to short-term weakness (-12.81% over two weeks), a medium-term fall (-47.07% over three months), and a longer-term loss (-100.0% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Acadia Healthcare Company, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -12.81%, with price expected at $18.17 by March 10, 2026, within a range of $16.69 to $19.60 3-Month Outlook: Projected fall of -47.07%, reaching $11.03 by May 25, 2026, with a range of $9.62 to $12.42. 1-Year Outlook: Projected loss of -100.0%, with price at $0.00 by February 24, 2027, within a range of $0.00 to $0.71.